Neuropharma S.A.S. is based in Ecuador, with the head office in Santo Domingo. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on January 03, 2024. There are currently 5 (2024) people employed by Neuropharma S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 76.93% in 2025. During that time, Neuropharma S.A.S.’s total assets grew by 135.68%. The net profit margin of Neuropharma S.A.S. increased by 0.76% in 2025.

Headquarters
Calle Cadmo Zambrano, 10
Santo Domingo; Santo Domingo de los Tsachilas;

Contact Details: Purchase the Neuropharma S.A.S. report to view the information.

Basic Information

Total Employees:

Purchase the Neuropharma S.A.S. report to view the information.

Registered Capital:

Purchase the Neuropharma S.A.S. report to view the information.

Financial Auditors:

Purchase the Neuropharma S.A.S. report to view the information.

Incorporation Date:

January 03, 2024

Key Executives

Purchase this report to view the information.

General Manager

Company Performance

Financial values in the chart are available after Neuropharma S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

76.93%▲

Total Operating Revenue

76.93%▲

Operating Profit

80.08%▲

EBITDA

80.28%▲

Net Profit/Loss for the Period

87.69%▲

Total Assets

135.68%▲

Total Equity

516.37%▲

Operating Profit Margin

0.29%▲

Net Profit Margin

0.76%▲

Return on Equity (ROE)

-65.71%▼

Quick Ratio

5.95%▲

Cash Ratio

4.28%▲

Neuropharma S.A.S. (Ecuador)

Similar companies